D
Patient 1
OUS MDR - AFTER AN IMPLANT DURATION OF APPROXIMATELY 71 MONTHS, OVERSENSING WAS REPORTED. NO ADVERSE PATIENT SIDE EFFECTS HAVE BEEN REPORTED. THE DEVICE WAS EXPLANTED.
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KENTROX RV-S 65 STEROID | ICD LEAD | BIOTRONIK SE & CO. KG | LWS | 343080 | 343080 | * | Y |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2011-12-27 | 0 | 1. H |
Patient 1
OUS MDR - AFTER AN IMPLANT DURATION OF APPROXIMATELY 71 MONTHS, OVERSENSING WAS REPORTED. NO ADVERSE PATIENT SIDE EFFECTS HAVE BEEN REPORTED. THE DEVICE WAS EXPLANTED.
Patient 1
OUS MDR.